Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Additional GUSTO III data supports efficacy and safety of Retavase

May 21, 1997

Design of bisoprolol CIBIS II study

May 21, 1997

Orion-Yhtyma discloses potent and selective alpha2-adrenoceptor agonists

May 21, 1997

Peptide P-selectin inhibitors described by Centocor

May 20, 1997

BMS describes angiotensin II antagonists

May 20, 1997

Ribi ImmunoChem offers licenses for cardioprotectant

May 19, 1997

Antiproliferative effects of PCA-4230 in vascular smooth muscle cells

May 16, 1997

SmithKline Beechan to market Kissei's tranilast

May 15, 1997

Antiischemic potassium channel activators described by BMS

May 15, 1997

Selective alpha1b-adrenoceptor blockers from Merck & Co.

May 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...